Profile
Trishna Goswami worked as a Senior Director-Medical at Stemline Therapeutics, Inc. from 2017 to 2018.
She then served as a Vice President-Clinical Development at Gilead Sciences, Inc. After that, she worked as a Vice President-Clinical Development at Immunomedics, Inc. from 2018 to 2021.
Currently, she is the Chief Medical Officer at IN8bio, Inc. starting from 2021 and ending in 2024.
Dr. Goswami holds an MBA from Robert H.
Smith School of Business and a doctorate from Drexel University College of Medicine.
Former positions of Trishna Goswami
| Companies | Position | End |
|---|---|---|
| IN8BIO, INC. | Chief Tech/Sci/R&D Officer | 2024-09-05 |
| IMMUNOMEDICS, INC. | Corporate Officer/Principal | 2021-11-30 |
| STEMLINE THERAPEUTICS, INC. | Corporate Officer/Principal | 2018-05-31 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | - |
Training of Trishna Goswami
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Gilead Sciences, Inc.
Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Immunomedics, Inc.
Immunomedics, Inc. BiotechnologyHealth Technology Develops drugs for the treatment of cancer | Health Technology |
Stemline Therapeutics, Inc.
Stemline Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel oncology therapeutics | Health Technology |
Robert H. Smith School of Business
Robert H. Smith School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Drexel University College of Medicine
Drexel University College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IN8bio, Inc.
IN8bio, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on delivering a novel off-the-shelf product for the treatment of cancer | Health Technology |
- Stock Market
- Insiders
- Trishna Goswami
















